Uniqure NV (NASDAQ:QURE)
| 32.87 Delayed Data As of 3:59pm ET |  +0.01 / +0.03%Today’s Change | 28.58 Today|||52-Week Range 71.45 | -9.02% Year-to-Date |
Latest QURE News | Press Releases
No recent news for Uniqure NV.
Today’s Trading
| Previous close | 32.86 |
| Today’s open | 33.00 |
| Day’s range | 32.32 - 33.17 |
| Volume | 9,719 |
| Average volume (3 months) | 448,065 |
| Market cap | $1.5B |
Data as of 3:59pm ET, 06/21/2021
Growth & Valuation
| Earnings growth (last year) | +9.45% |
| Earnings growth (this year) | +154.32% |
| Earnings growth (next 5 years) | -26.60% |
| Revenue growth (last year) | +415.23% |
| P/E ratio | NM |
| Price/Sales | 42.83 |
| Price/Book | 6.05 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RGNXRegenxbio Inc | +0.49 | +1.30% |
| SGMOSangamo Therapeutics... | +0.21 | +1.85% |
| SAVACassava Sciences Inc | +10.34 | +13.00% |
| AUPHAurinia Pharmaceutic... | +0.42 | +3.23% |
Data as of 4:46pm ET, 06/21/2021
Financials
| Next reporting date | August 4, 2021 |
| EPS forecast (this quarter) | $2.97 |
| Annual revenue (last year) | $37.5M |
| Annual profit (last year) | -$125.0M |
| Net profit margin | -333.27% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Amsterdam, Noord-holland |
Forecasts
